Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_assertion type Assertion NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_head.
- NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_assertion description "[We recently reported that CD44 variant isoforms (CD44v) on LS174T colon carcinoma cells possess selectin binding activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_provenance.
- NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_assertion evidence source_evidence_literature NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_provenance.
- NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_assertion SIO_000772 17135256 NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_provenance.
- NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_assertion wasDerivedFrom befree-2016 NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_provenance.
- NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_assertion wasGeneratedBy ECO_0000203 NP581737.RAg5rZ06CS25Oxbe6_1fWFdMk0BVEwFcsW9Bb7H66WshA130_provenance.